Printer Friendly

Implanted device could reduce risk of stroke in atrial fibrillation.

An international team of researchers has successfully completed clinical trials of a device that could greatly reduce the risk of stroke for some people with atrial fibrillation.

The device, made of a self-expanding alloy cage with a polymer covering, was tested on 15 patients with chronic atrial fibrillation and a high risk for stroke. The implant was inserted into the left atrial appendage, a small pouch in the heart's left upper pumping chamber, in which blood clots can easily form. No complications associated with the device were seen in any of the patients after more than 6 months of followup, and the researchers are hopeful that it will serve as an alternative to chronic anticoagulant therapy. (Circulation 2002; published online April 8.)
COPYRIGHT 2002 Transplant Communications, Inc.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2002 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Comment:Implanted device could reduce risk of stroke in atrial fibrillation.(Brief Article)
Publication:Transplant News
Article Type:Brief Article
Geographic Code:00WOR
Date:Jun 14, 2002
Words:122
Previous Article:Bioengineered skin interacts like living tissue with host.
Next Article:Bull clone puzzles Brazil scientists anticipating a cow.
Topics:


Related Articles
ACCP REDEFINES STANDARD OF CARE FOR ATRIAL FIBRILLATION.
About atrial fibrillation.

Terms of use | Privacy policy | Copyright © 2022 Farlex, Inc. | Feedback | For webmasters |